Remove 2022 Remove Compounding Remove Medical Records
article thumbnail

AmerisourceBergen aims to make digital therapeutics access easier

pharmaphorum

AmerisourceBergen notes that the US market for DTx is predicted to grow at a compound annual growth rate of nearly 25% between 2022 to 2030, according to figures from Grand View Research which valued the category at $4.2 billion in 2021.

article thumbnail

Unlocking disease treatment with large-scale research

pharmaphorum

The power of AI is also being harnessed to sift through vast amounts of data to determine potential areas of treatment or to discover new uses for old compounds. The research programme was officially launched at the end of October 2022, and has the aim of building a resource of five million individuals’ information by 2025.